COVID vaccine clot study scrapped before start
NCT ID NCT04889326
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to collect medical information from people who developed unusual blood clots within four weeks of receiving a COVID-19 vaccine. The goal was to better understand any possible link between the vaccine and these rare events. However, the study was withdrawn before enrolling any participants, so no data was collected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU lille
Lille, 59037, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 15-Minute chat at a testing site boost COVID-19 vaccination?
- E-Ink screens in ERs could boost patient satisfaction
- New clot-sucking device tested in real-world vein clot treatment
- Blood thinners after vein laser: which works best to stop dangerous clots?
- Cord blood cells aim to speed platelet recovery in transplant patients
- Massive study tracks how lockdowns shaped mental health across america